LSTM leads project to develop HIV/AIDS strategy for Libya
Liverpool School of Tropical Medicine (LSTM) is leading a project to provide technical assistance to the Libyan government to finalise the development of a national HIV strategy and programme of support. The project is supported by a 1 million grant from the Delegation of the European Commission ...Innovator's Studio launches new forum for Chief Strategy Officers October 26-27, 2009
The Strategy Group announces the October kickoff of a new forum for chief strategy officers as part of The Innovator's Studio, a collaborative incubator for market-leading health systems seeking to create competitive advantage through value innovation. Norfolk, Virginia...Innovator's Studio offers Social Media Strategy Intensive Sept 16-17, 2009
The Strategy Group announces a social media strategy intensive designed specifically to help hospitals and health systems incorporate social media into marketing strategy. The 2-day session, entitled, Social Media: It's All About Strategy, is scheduled for Sept 16-17, 2009 in Chicago, IL. ...Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
DALLAS, July 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) , announced today that it is evaluating strategic options for the commercialization of MuGard in North America. MuGard is an FDA approved treatment for oral mucositis, a debilitat...New strategy in tumor treatment
A new strategy proposed by researchers at Dartmouth Medical School and Amtek, Hanover, NH may treat tumors that do not respond to conventional treatment. The study, which was published on May 29th in the open access, peer reviewed journal PLoS ONE , uses a combination of two agents to selectively...PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
ANNAPOLIS, Md., May 22 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company has submitted its comprehensive regulatory strategy to the U.S. Food and Drug ...ActivBiotics Proposes Development Strategy for Its Novel Rifamycin Antibiotics
WELLESLEY HILLS, Mass., Feb. 25 /PRNewswire/ -- Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, as a result of growing interest from prospective buyers, announced today a development strategy for further advancement of the company's proprietary benzoxazinor...Interim Mobile Cardiac Catheterization and Angiography Services
Description:...mpany delivers the equipment and provides applications training to your hospital staff. MedCath Diagnostics gives your hospital a cost-effective strategy for meeting your interim challenges. When your hospital's reputation is on the line, turn to our professionals to help put a permanent solution to you...VerdaSee Navigator Tracking and Tracing Software
Features:...ets, consumables or even people. All products developed by VerdaSee are designed to be technology agnostic. Navigator Server plays a key role in this strategy by interfacing with multiple data collection technologies such as active RFID, passive RFID, bar code, and more. The data processing capabilities of ...New therapeutic strategy could target toxic protein in most patients with Huntington's disease
Howard Hughes Medical Institute researchers have designed tiny RNA molecules that shut off the gene that causes Huntington's disease without damaging that gene's healthy counterpart, which maintains the health and vitality of neurons. Laboratory studies suggest that a single small interfering RNA ...Therapeutic hypothermia is promising strategy to minimize tissue damage
New Rochelle, NY, March 19, 2009Recognition of the benefits of cooling strategies to protect the brain and spinal cord after traumatic injury has led to a wealth of cutting edge research, prime examples of which are featured in a special hypothermia issue of Journal of Neurotrauma , a peer-review...RNA research strategy for Europe takes shape
Research into RNA, a molecule found in every cell of our bodies, could lead to remarkable advances in the treatment of diseases such as cancer and diabetes, a meeting organised by the European Science Foundation was told. The conference, held the institute of Parasitologa y Biomedicina "Lpez-Ne...Hope for a rabies eradication strategy in Africa
Most of the rabies virus circulating in dogs in western and central Africa comes from a common ancestor introduced to the continent around 200 years ago, probably by European colonialists. In the current issue of Journal of General Virology a team of scientists from Africa, USA and France report...Mitochondria could be a target for therapeutic strategy for Alzheimer's disease patients
New York (Sept. 21, 2008) A study in the Sept. 21 on-line edition of Nature Medicine describes the function and interaction of a critical molecule involved in cell death in Alzheimer's disease patients. These new findings reveal that blocking this molecule, called Cyclophilin D (CypD), and deve...GUMC researchers hone in on new strategy to treat common infection
Washington, DC -- Researchers at Georgetown University Medical Center (GUMC) have successfully tested a genetic strategy designed to improve treatment of human infections caused by the yeast Candida albicans , ranging from diaper rash, vaginitis, oral infections (or thrush which is common in HIV/...China Biologic Products Hosts its First Forum for Strategy and Development
TAIAN CITY, China, July 16 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), today announced that the Company hosted a ...Arpida to Discuss Strategy With Shareholders
REINACH, Switzerland, May 7 /PRNewswire-FirstCall/ -- Arpida Ltd. (SIX: ARPN) will today discuss potential strategic scenarios with its shareholders during the Annual General Meeting (AGM) which starts at 10am CET in Reinach, Switzerland. After the negative FDA opinion regarding intrave...Healthplace America Engages Robert A. Yungk to Provide Services as Chief Strategy Officer
Mr. Yungk to Direct Strategic Development of the Company's National Network of Medical Provider Best Practice Leaders LISLE, Ill., April 7 /PRNewswire/ -- Healthplace America, the country's first and only Surgery Benefit Management(TM) solution company, is engaging the services of Robert A. Y...Independent Study Corroborates Prana's Strategy to Treat Alzheimer's Disease Patients.
- Journal of Neuroscience paper describes role of Zinc in developing Alzheimer's - MELBOURNE, Australia, April 1 /PRNewswire-FirstCall/ -- Prana Biotechnology (ASX:PBT; Nasdaq: PRAN ) today announced that an independent study conducted by researchers at the University of California, Irvine...Aethlon Medical Announces Data Supported Strategy to Increase Hepatitis-C (HCV) Cure Rates
SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD) today announced clinical data that supports the advancement of the Aethlon Hemopurifier(R) as an adjunct therapy to increase Hepatitis-C (HCV) cure rates. The Hemopurifier(R) is a first-in-class medical ...ProPrep BAC 960 from Biotech Support Group
Description:...tion from 1.5ml 2xYT cultures; Provides high-quality DNA suitable for automated fluorescent sequencing for small to large insert DNA; Utilizes ProPrep strategy which minimizes shearing and improves yield; Adapts easily to robots and automation....ProPrep BAC 960 from Biotech Support Group
Description:...tion from 1.5ml 2xYT cultures; Provides high-quality DNA suitable for automated fluorescent sequencing for small to large insert DNA; Utilizes ProPrep strategy which minimizes shearing and improves yield; Adapts easily to robots and automation....microPET Focus 120 from CTI Molecular Imaging, Inc.
Description:...ide the most complete and integrated product line, including PET scanners, cyclotrons, molecular probes, detector materials, and support services. Our strategy is to capitalize on our breadth in PET and provide the only "total solution" for healthcare providers. We distribute a wide range of products for bot...microPET R4 from CTI Molecular Imaging, Inc.
Description:...ide the most complete and integrated product line, including PET scanners, cyclotrons, molecular probes, detector materials, and support services. Our strategy is to capitalize on our breadth in PET and provide the only "total solution" for healthcare providers. We distribute a wide range of products for bot...microPET Focus 220 from CTI Molecular Imaging, Inc.
Description:...ide the most complete and integrated product line, including PET scanners, cyclotrons, molecular probes, detector materials, and support services. Our strategy is to capitalize on our breadth in PET and provide the only "total solution" for healthcare providers. We distribute a wide range of products for bot...Hybridoma Development from Covance Research Products, Inc
Description:...ce has generated hybridomas against a large variety of antigens. Prior to project initiation, you are provided with personalized project proposals and strategy consultation. Hybridoma cell lines developed by Covance remain exclusive property of the client. A typical hybridoma development project has four phas...